Search results
Results from the WOW.Com Content Network
Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX) Q3 2024 Earnings Call Nov 04, 2024, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina.The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases.
Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX) Q2 2024 Earnings Call Aug 05, 2024, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
[24] [25] In December 2021, Stocktwits raised 30M$ for its seed B funding round and announced its next big moves including a boost in its crypto coverage and plans to launch in India by Q2 in 2022. The series B funding set Stocktwits at a valuation of $210 million. [26] In February 2022, Stocktwits launched its crypto trading platform. [24]
BioCryst (BCRX) obtains FDA ... 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...